An update from BiomX (PHGE) is now available.
At the Annual Meeting, shareholders of the Company decisively voted to increase the authorized shares of common stock from 120 million to 750 million, signaling a strategic expansion move. Other approved proposals included the conversion of preferred stock and warrants into common stock, the restatement of the long-term incentive plan, the election of board directors, and advisory votes on executive compensation and its frequency, with a triennial review now adopted. Additionally, a reverse stock split and the ratification of an independent auditor were sanctioned, reflecting a proactive approach to corporate governance and financial oversight.
Find detailed analytics on PHGE stock on TipRanks’ Stock Analysis page.
